Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|8|586-592

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.8, 2006-10, pp. : 586-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Approaches to Chronic Intestinal Inflammation by Specific Targeting of Mucosal IL-7 / IL-7R Signal Pathway

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 119-123

Bentham Science Publishers

Access to resources Recommend Favorite

BCG vaccine: BCGitis in an infant with an IL-12 receptor deficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity

By Kreymborg Katharina   Böhlmann Ulrike   Becher Burkhard  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1123-1136

Informa Healthcare

Access to resources Recommend Favorite

The Rational Design of Vaccine Adjuvants for Mucosal and Neonatal Immunization

By  

Current Medicinal Chemistry, Vol. 8, Iss. 9, 2001-07 ,pp. : 1057-1075

Bentham Science Publishers

Access to resources Recommend Favorite

IL-15 improves neutrophil activity in HIV infection

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite